StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
The company has a market cap of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a 1 year low of $0.01 and a 1 year high of $1.99.
Athersys Company Profile
Want More Great Investing Ideas?
Further Reading
- Five stocks we like better than Athersys
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What is the Euro STOXX 50 Index?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Where to Find Earnings Call Transcripts
- Time to Load Up on Home Builders?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
